217 related articles for article (PubMed ID: 25652099)
1. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
[TBL] [Abstract][Full Text] [Related]
2. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
[TBL] [Abstract][Full Text] [Related]
3. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
[TBL] [Abstract][Full Text] [Related]
4. Silencing HO-1 sensitizes SKM-1 cells to apoptosis induced by low concentration 5-azacytidine through enhancing p16 demethylation.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Lu T; Cao L
Int J Oncol; 2015 Mar; 46(3):1317-27. PubMed ID: 25585641
[TBL] [Abstract][Full Text] [Related]
5. [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS].
Zhang Y; Song LX; Wu LY; Chang CK; Li X
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):237-41. PubMed ID: 23683424
[TBL] [Abstract][Full Text] [Related]
6. [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro].
Yang L; Xu RR; Song GQ; Hang HM; Liu H; Jiang SH; Wang XF; Ding XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):819-23. PubMed ID: 18718068
[TBL] [Abstract][Full Text] [Related]
7. [Functional study of hENT1 on SKM-1 cell resistance to decitabine].
Shi W; Wu L; Guo J; Xu F; Chang C; Li X
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):408-12. PubMed ID: 26031529
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
[TBL] [Abstract][Full Text] [Related]
9. HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia.
He Z; Zhang S; Ma D; Fang Q; Yang L; Shen S; Chen Y; Ren L; Wang J
J Transl Med; 2019 Nov; 17(1):366. PubMed ID: 31711520
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.
Kimura S; Kuramoto K; Homan J; Naruoka H; Ego T; Nogawa M; Sugahara S; Naito H
Anticancer Res; 2012 Mar; 32(3):795-8. PubMed ID: 22399596
[TBL] [Abstract][Full Text] [Related]
11. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Ye XS; Liu T; Cui X; Meng WT; Xi YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
[TBL] [Abstract][Full Text] [Related]
13. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
Hackanson B; Robbel C; Wijermans P; Lübbert M
Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
[TBL] [Abstract][Full Text] [Related]
14. High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.
Wu L; Shi W; Li X; Chang C; Xu F; He Q; Wu D; Su J; Zhou L; Song L; Xiao C; Zhang Z
J Transl Med; 2016 Mar; 14():66. PubMed ID: 26944860
[TBL] [Abstract][Full Text] [Related]
15. [Biologic changes in MDS-L cell line induced by As2O3 and/or TRAIL].
Li X; Pu Q; Shen WM; Tohyama K; Deeg HJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):605-9. PubMed ID: 15634594
[TBL] [Abstract][Full Text] [Related]
16. Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines.
Berg T; Guo Y; Abdelkarim M; Fliegauf M; Lübbert M
Leuk Res; 2007 Apr; 31(4):497-506. PubMed ID: 17056112
[TBL] [Abstract][Full Text] [Related]
17. [The re-expression of p15(INK4B) gene in leukemia cells induced by in vitro DNA methyltransferase and histone deacetylase inhibition].
Ren L; Du H; Zhu Q; Shi Y; Chen H; Wu S
Zhonghua Nei Ke Za Zhi; 2002 Nov; 41(11):762-5. PubMed ID: 12485524
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes.
Zou J; Zhou Z; Wan L; Tong Y; Qin Y; Wang C; Zhou K
PLoS One; 2015; 10(8):e0136843. PubMed ID: 26317501
[TBL] [Abstract][Full Text] [Related]
19. The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome.
Wu P; Geng S; Weng J; Deng C; Lu Z; Luo C; Du X
Leuk Res; 2015 Feb; 39(2):216-20. PubMed ID: 25533931
[TBL] [Abstract][Full Text] [Related]
20. [Abnormality of p15(INK4b) gene and myelodysplastic syndrome].
Wang Z; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):362-5. PubMed ID: 12513775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
